Replies to post #13127 on GT Biopharma Inc (GTBP)

[BullsOnFire]

Immuno-oncology, one of the pillars of cancer treatment, is driving engagement worldwide among biotech, large pharma, universities/cancer centers and the financial investment community. Currently, more than 130 biotech and 20 pharma companies are developing immuno-oncology therapies and GT Biopharma is one of a leading pharma company! $GTBP

[BullsOnFire]

or you can say Immuno Oncology is to traditional chemo what UBER was to traditional TAXI and: the future has arrived.

[BullsOnFire]

Immuno Oncology is to cancer what smart bombs are to terrorists. It drops a Hellfire missile in the bad guy's lap without damaging the school next door. No collateral damage. The therapy can be calibrated to go only after the cancer cells or cancer stem cells, without damaging healthy cells. It can harness the bodies own "killer cells" to go after cancer cells and deliver deadly "payloads" to those malignant cells alone. This is a huge win not only against cancer, but for the dignity and quality of human life in the midst of medical treatment. It is not just a medicine, it is a victory for humanity.